AMRUTANJAN vs PFIZER: Stock Comparison

Amrutanjan Health Care Limited vs Pfizer Limited

Live data: 22 July 2026, 3:03 PM IST • Source: NSE and company filings

Pfizer Limited is the larger company by market capitalisation. Amrutanjan Health Care Limited shows a lower P/E, a higher ROE and faster revenue growth, while Pfizer Limited shows a higher dividend yield, lower leverage and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Amrutanjan Health Care Limited and Pfizer Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, AMRUTANJAN is more favourable on 7 of 11 scored metrics and PFIZER on 4These counts are context-free and are not an overall rating.

Amrutanjan Health Care Limited

Key Differences

Market Cap

PFIZER is the larger company

₹21,242 Cr vs ₹1,537 Cr

P/E Ratio

AMRUTANJAN has a lower P/E

26.9x vs 29.12x

P/B Ratio

AMRUTANJAN has a lower P/B

4.21x vs 5.01x

EPS

PFIZER has higher earnings per share

₹157.72 vs ₹20.01

Dividend Yield

PFIZER has a higher dividend yield

2.83% vs 1.02%

Revenue Growth (TTM YoY)

AMRUTANJAN has faster revenue growth

10.5% vs 6.3%

EPS Growth (TTM YoY)

AMRUTANJAN has faster EPS growth

6.7% vs -39.6%

ROE

AMRUTANJAN has a higher ROE

20% vs 19.8%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

Metric	AMRUTANJAN	PFIZER
Sector	Healthcare	Healthcare
Industry	Pharmaceuticals	Pharmaceuticals

Price

Metric	AMRUTANJAN	PFIZER
Live Price	₹530.25	₹4,650.2
Day Change	-1.55%	1.24%
Volume	21,624	19,734
52-Week High	₹790.95	₹5,873.5
52-Week Low	₹486	₹4,360.1
Distance from 52W High	-32.96%	-20.83%

Valuation

Metric	AMRUTANJAN	PFIZER
Market Cap	₹1,537 Cr	₹21,242 Cr
P/E Ratio	26.9x	29.12x
P/B Ratio	4.21x	5.01x
EPS	₹20.01	₹157.72
Book Value	₹128.04	₹918.74
Dividend Yield	1.02%	2.83%

Growth

Metric	AMRUTANJAN	PFIZER
Revenue Growth (TTM YoY)	10.5%	6.3%
EPS Growth (TTM YoY)	6.7%	-39.6%

Profitability & Leverage

Metric	AMRUTANJAN	PFIZER
ROE	20%	19.8%
ROCE	31.4%	27.2%
Net Margin	11.52%	28.67%
Operating Margin	17.7%	-12.1%
Debt to Equity	0.02x	0x

Shareholding

As of Jun 2026 • change vs previous quarter

Metric	AMRUTANJAN	PFIZER
Promoter Holding	46.52%	63.92%
FII Holding	2.44%▲ 0.27 pp	1.65%▼ 1.16 pp
DII Holding	12.28%▼ 0.38 pp	17.8%▲ 0.91 pp
Public Holding	38.72%▲ 0.11 pp	16.63%▲ 0.26 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Amrutanjan Health Care Limited and Pfizer Limited.

Related Comparisons

Infosys vs TCS HDFC Bank vs ICICI Bank Axis Bank vs Kotak Mahindra Bank HCL Technologies vs Wipro Hindustan Unilever vs ITC Maruti Suzuki vs Tata Motors

Browse all stock comparisons →

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.